Anti-MLV p30 antibody [4B2] (STJA0002865)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG
ImmunogenFull length recombinant MLV-Gag p30 capside protein, purified from E. coli. MLV p30
General Information
| Short Description | Mouse monoclonal anti-MLV p30 for use in ELISA and WB in MLV samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA/WB |
| Host | Mouse |
| Reactivity | MLV |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 4B2 |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Purification | Protein G purification |
| Dilution Range | ELISA 0.05-0.1 µg/ml; WB 0.5 µg/mlMonoclonal antibody working titer has to be established practically for each particular antigen and assay format |
| Formulation | PBS pH 7.4, 0.1% sodium azide |
| Storage Instruction | Store at-20 to-70 °C upon receipt. Divide antibody into aliquots prior usage. Avoid multiple freeze-thaw cycles |
Target Information
| Immunogen | Full length recombinant MLV-Gag p30 capside protein, purified from E. coli. MLV p30 |
| Specificity | MLV Gag, p30 |
Additional Info
| Background | Murine leukemia viruses belong to family of Retroviruses group and are named for their ability to cause cancer in mice. Some form of MLV s are used in cancer research. The retroviral Gag protein plays important roles at several stages in the viral life cycle. Late in infection, the Gag precursor protein acts to mediate the assembly and release of virion particles. After budding, the core matures by cleavageof Gag precursor protein into the mature core proteins, the matrix (MA) , capsid (CA) and nucleocapsid proteins. These separated Gag proteins then play roles in the early stages of infection |
Information sourced from Uniprot.org